HD Focus

A ABH está de malas prontas para a Colômbia! ✈️🇨🇴 Entre os dias 2 e 4 de setembro, participaremos do 3º Congresso Latino-Americano da Doença de Huntington, na cidade de Medellín. O evento, organizado pela Factor-H, contará com a presença de médicos, cientistas, associações de familiares e jovens lideranças de todo o mundo. Assim como […]

O post ABH estará presente no 3º Congresso Latino-Americano da Doença de Huntington apareceu primeiro em ABH – Associação Brasil Huntington.

A new Phase 1 study is testing SRP-1005, a huntingtin-lowering therapy given by injection under the skin. It’s early days, but this approach could add an important new arrow to the HD drug development quiver.

Lunchwebbinarium om stärkt stöd till anhöriga med Martina Takter Den 1 juli började flera nya lagar att gälla. Bland annat en ny lagstiftning som stärker stödet till anhöriga. För kommuner, chefer och medarbetare inom socialtjänst, vård och omsorg innebär förändringarna både nya möjligheter och ett ökat ansvar att utveckla ett hållbart och förebyggande stöd till…

Inlägget 24 augusti – Lunchwebbinarium dök först upp på RHS Riksförbundet Huntingtons Sjukdom.

CBER (Center for Biologics Evaluation and Research) and CDER (Center for Drug Evaluation and Research) are two major centers within the U.S. Food and Drug Administration, each responsible for regulating different types of medical products: CBER: Focus: Regulates biologics—products derived from living organisms. Products regulated: Vaccines, blood and blood products, gene therapies, cellular therapies, allergenic extracts, and some medical devices related to these products. Examples: Influenza...

Saiba quais são os novos centros brasileiros que já iniciaram a fase de recrutamento de pacientes para o estudo clínico FALCON-HD.

O post Novos centros de pesquisa do FALCON-HD com recrutamento ativo apareceu primeiro em ABH – Associação Brasil Huntington.

⏱️ 5 min read | Announcing the 2026 HDBuzz Prize for Young Science Writers – sponsored by the Hereditary Disease Foundation!

Palestras, Roda de Conversa e muito afeto: garanta sua vaga no encontro presencial da ABH que conectará famílias, cuidadores e profissionais da saúde.

O post Reserve na agenda: Huntington em Encontro chega a Curitiba apareceu primeiro em ABH – Associação Brasil Huntington.

Deň 1. Konferenciu otvorila profesorka Anna Rosser. A hovorila o príznakoch HCH, aby aj vedci pracujúci v laboratóriách vedeli aké náročné to môže byť pre rodiny žijúcimi s HCH.  Ďalšie prednášky boli o zisteniach získaných pri výskume darovaných mozgov a spojitosti poškodených častí s príznakmi HCH. Hovorili aj o rôznych formách HCH na základe prvých …

Konferencia HD 2026 – Miltona Wexlera Čítajte viac »

Our supporters do really amazing things – including new volunteer fundraiser Geoff Cooper who is all set to cycle across […]

Day 3 of #HD2026 put HTT under the microscope. Researchers shared new insights into HTT1a, next-generation HTT-lowering approaches, somatic expansion, brain circuitry, and why boosting healthy HTT might help. Read our roundup here.

⏱️ 23 min read | Day 2 of #HD2026 brought us updates on the mechanics of somatic instability, new ways to track HD in people, AI tools to help drive research forward, and developments in our understanding of the HTT protein. Catch up right here.

Digital föräldragrupp för dig som har ett barn med juvenil Huntingtons sjukdom Har du ett barn med juvenil Huntingtons sjukdom? Välkommen att delta i en digital föräldragrupp för föräldrar till barn med sällsynta hälsotillstånd. I gruppen får du möjlighet att träffa andra föräldrar som, precis som du, har erfarenhet av att vara förälder till ett…

Inlägget Digital föräldragrupp! dök först upp på RHS Riksförbundet Huntingtons Sjukdom.

⏱️ 28 min read | Day1 of HD2026 is a wrap! From what human brains can teach us about HD, to HTT1a, somatic CAG expansion and the normal biology of HTT, today’s talks spanned the spectrum from fundamental biology to potential treatments.

Op zaterdag 17 oktober houdt de Vereniging van Huntington weer een Jongerendag. Ben jij tussen de 18 en 45 jaar oud en betrokken bij de ziekte van Huntington? Dan ben je van harte welkom in Ede voor een dag vol ontmoeting, een lekkere lunch én een professionele sushiworkshop.

aktualizácia 11.8.2026 Prelinea sa podelila o výsledky z placebo skupín s CHDI (Nadáciou ktorá financuje výskum HCH).  Takto sa využije aj vedecký potenciál ľudí, ktorý sa zúčastnili a ich účasť tak získa významnú pridanú hodnotu pre ďalší výskum. Originál článku tu. aktualizácia 19.5.2026 Žiadosť o schválenie Pridopidínu bola stiahnutá. EMA vyhodnotila liek vo všetkých skupinách ako …

Pridopidin Čítajte viac »

There are so many things that people in the Huntington’s Community never talk about. Especially the Caregivers or Care Partners (whatever your choice of description may be.) You think you know how hard this journey into Caregiving is going to be, but until you actually live it, you have no clue. It’s easy for those on the outside looking in to give suggestions that they think are helpful but really aren’t. One of the biggest things a Caregiver won’t tell you about is the guilt. Guilt for...

Onderzoekers van het Maastricht UMC+ onderzoeken of het ziekmakende eiwit bij de ziekte van Huntington betrouwbaar gemeten kan worden in traanvocht. Als dit lukt, kan dit in de toekomst een patiëntvriendelijk alternatief bieden voor de ingrijpende ruggenprik. Om de meetresultaten goed te kunnen vergelijken, zoekt het onderzoeksteam gezonde controlepersonen.

Ferrer and Prilenia are pleased to update you that the first participant has been randomized in the PRECISE-HD confirmatory Phase 3 study of pridopidine, an investigational medicinal product taken as an oral capsule twice daily, in Huntington’s disease (HD). This milestone marks the start of participant enrolment, with several US sites now active and additional sites in Canada, the EU and the UK set to follow later this year. PRECISE-HD is designed to further evaluate the efficacy and safety...

Clinical trial data can drive discovery long after a study ends. Prilenia donated placebo-arm data from 2 HD clinical trials to CHDI, a valuable resource for researchers to better understand placebo effects, HD progression and future trial design.

Because of an amazing private donor, we are able to offer 10 full scholarships to attend Help 4 HD's annual Symposium for first-time attendees. Restrictions apply; please read carefully before applying. https://www.help4hd.org/events-1/full-scholarships-to-help-4-hds-annual-symposium-1